Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Davis

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|May 27, 2020
Population Pharmacodynamic Model of Neutrophil Margination and Tolerance to Describe Effect of Sarilumab on Absolute Neutrophil Count in Patients with Rheumatoid ArthritisPavel Kovalenko, Anne Paccaly, Anita Boyapati, et al.
Journal of Clinical Pharmacology|July 30, 2020
Pharmacokinetics and Pharmacodynamics of Subcutaneous Sarilumab and Intravenous Tocilizumab Following Single-Dose Administration in Patients With Active Rheumatoid Arthritis on Stable MethotrexateAnne J Paccaly, Pavel Kovalenko, Janie Parrino, et al.
British Journal of Clinical Pharmacology|April 22, 2010
Translational pharmacokinetic-pharmacodynamic modelling; application to cardiovascular safety data for PF-00821385, a novel HIV agentGrant Langdon, John D Davis, Lynn M McFadyen, et al.
Clinical and Translational Science|August 26, 2021
REGN1908-1909 monoclonal antibodies block Fel d 1 in cat allergic subjects: Translational pharmacokinetics and pharmacodynamicsMohamed A Kamal, Robert Dingman, Claire Q Wang, et al.
Journal of Clinical Pharmacology|November 18, 2021
Pharmacokinetics and Concentration-Response of Dupilumab in Patients With Seasonal Allergic RhinitisMohamed A Kamal, Yoko Franchetti, Ching-Ha Lai, et al.
Journal of Clinical Pharmacology|June 20, 2020
Pharmacokinetics and Pharmacodynamics of Garetosmab (Anti-Activin A): Results From a First-in-Human Phase 1 StudyFrédéric Vanhoutte, Su Liang, Marcella Ruddy, et al.
Clinical and Translational Science|April 9, 2024
Pharmacokinetics and pharmacodynamics of mibavademab (a leptin receptor agonist): Results from a first-in-human phase I studyAndrew Gewitz, Jeanne Mendell, Yuhuan Wang, et al.
Clinical and Translational Science|August 20, 2022
Pharmacokinetics, pharmacodynamics, and exposure-efficacy of dupilumab in adults with atopic dermatitisMohamed A Kamal, John D Davis, Pavel Kovalenko, et al.
Clinical Pharmacology in Drug Development|February 26, 2020
Base and Covariate Population Pharmacokinetic Analyses of Dupilumab Using Phase 3 DataPavel Kovalenko, John D Davis, Meng Li, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 28, 2017
Combining "Bottom-up" and "Top-down" Approaches to Assess the Impact of Food and Gastric pH on Pictilisib (GDC-0941) PharmacokineticsTong Lu, Grazyna Fraczkiewicz, Laurent Salphati, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
CPT: Pharmacometrics & Systems Pharmacology|May 27, 2020
Population Pharmacodynamic Model of Neutrophil Margination and Tolerance to Describe Effect of Sarilumab on Absolute Neutrophil Count in Patients with Rheumatoid ArthritisPavel Kovalenko, Anne Paccaly, Anita Boyapati, et al.
Journal of Clinical Pharmacology|July 30, 2020
Pharmacokinetics and Pharmacodynamics of Subcutaneous Sarilumab and Intravenous Tocilizumab Following Single-Dose Administration in Patients With Active Rheumatoid Arthritis on Stable MethotrexateAnne J Paccaly, Pavel Kovalenko, Janie Parrino, et al.
British Journal of Clinical Pharmacology|April 22, 2010
Translational pharmacokinetic-pharmacodynamic modelling; application to cardiovascular safety data for PF-00821385, a novel HIV agentGrant Langdon, John D Davis, Lynn M McFadyen, et al.
Clinical and Translational Science|August 26, 2021
REGN1908-1909 monoclonal antibodies block Fel d 1 in cat allergic subjects: Translational pharmacokinetics and pharmacodynamicsMohamed A Kamal, Robert Dingman, Claire Q Wang, et al.
Journal of Clinical Pharmacology|November 18, 2021
Pharmacokinetics and Concentration-Response of Dupilumab in Patients With Seasonal Allergic RhinitisMohamed A Kamal, Yoko Franchetti, Ching-Ha Lai, et al.
Journal of Clinical Pharmacology|June 20, 2020
Pharmacokinetics and Pharmacodynamics of Garetosmab (Anti-Activin A): Results From a First-in-Human Phase 1 StudyFrédéric Vanhoutte, Su Liang, Marcella Ruddy, et al.
Clinical and Translational Science|April 9, 2024
Pharmacokinetics and pharmacodynamics of mibavademab (a leptin receptor agonist): Results from a first-in-human phase I studyAndrew Gewitz, Jeanne Mendell, Yuhuan Wang, et al.
Clinical and Translational Science|August 20, 2022
Pharmacokinetics, pharmacodynamics, and exposure-efficacy of dupilumab in adults with atopic dermatitisMohamed A Kamal, John D Davis, Pavel Kovalenko, et al.
Clinical Pharmacology in Drug Development|February 26, 2020
Base and Covariate Population Pharmacokinetic Analyses of Dupilumab Using Phase 3 DataPavel Kovalenko, John D Davis, Meng Li, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 28, 2017
Combining "Bottom-up" and "Top-down" Approaches to Assess the Impact of Food and Gastric pH on Pictilisib (GDC-0941) PharmacokineticsTong Lu, Grazyna Fraczkiewicz, Laurent Salphati, et al.
Pageof 9